#USA #Irvine #Allergan #SkinMedica #Regenerative Science

SkinMedica® Makes Strides in Regenerative Science

SkinMedica, a reputable brand under Allergan Aesthetics, recently revealed its enhanced commitment to advancing regenerative science, marking a significant milestone in its ongoing research endeavors. This move is part of a broader strategy aimed at pioneering innovations that will drive further understanding of skin health and wellness. Glen Curran, Senior Vice President at Allergan Aesthetics, highlighted the brand's longstanding roots in regenerative skincare, stemming from its focus on wound healing over the past 25 years.

Establishing the Regenerative Science Advisory Board

As a cornerstone of its renewed commitment, SkinMedica has proudly established the Regenerative Science Advisory Board. This board consists of accomplished physicians, clinicians, and skin health specialists from across the United States. Their role is to create a dialogue centered on scientific advancements, clinical best practices, and effective patient care solutions. Curran expressed optimism about the board's potential, stating, "Scientific innovation is most impactful when led by those who apply it in real-world scenarios." This collaborative effort is designed not only to inform future skin health discussions but also to provide actionable insights that can significantly benefit both providers and patients alike.

Expanding Research and Development Facilities

Complementing the advisory board's role, Allergan Aesthetics is investing in an extensive expansion of the SkinMedica research and development lab located in Irvine, California. This state-of-the-art facility incorporates advanced imaging technologies and pre-clinical research capabilities, allowing for deeper insights into skin biology. Notably, in this era of powerful technological advancement, SkinMedica is leveraging artificial intelligence and machine learning to expedite ingredient discovery and effectively focus on the biological components that contribute to skin longevity. Prithwiraj Maitra, Ph.D., Vice President of Global Skincare R&D at Allergan Aesthetics, emphasized the importance of this fusion of advanced technology and clinical expertise in shaping the future of skincare innovation.

Flagship Retail Experiences: A New Dimension in Patient Care

In addition to these impressive developments in research, SkinMedica has unveiled its first flagship retail experiences at selected medical aesthetics practices throughout the country. These immersive environments aim to elevate the patient experience beyond traditional clinical settings. By enabling patients to explore SkinMedica products and engage with the scientific foundations behind their efficacy, these flagship locations represent a significant leap in how skincare is approached and understood. Initial locations include Lycia Thornburg, M.D. Dermatology in Rapid City, South Dakota, and The Skin Clinic in Scottsdale, Arizona, with plans for further expansion across key U.S. markets in the coming year.

Commitment to Patient-Centric Solutions

Through these initiatives, SkinMedica is reinforcing its mission to enhance skin health, from foundational research to patient interactions. By continuously exploring innovative pathways and establishing meaningful connections among clinicians, innovators, and patients, SkinMedica seeks to transform the landscape of regenerative skincare.

For further information about SkinMedica's cutting-edge offerings and the latest developments in regenerative science, visit SkinMedica.com and connect with the brand on social media via Instagram @SkinMedica.

SkinMedica remains dedicated to the principles of scientific excellence, aiming to bridge gaps in skincare with pioneering innovations that meet the evolving needs of its clientele.